← All stories
Markets
Faron Pharmaceuticals (FARN) to Release H1 2026 Financial Results on August 26 with Live Investor Webcast
Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical firm headquartered in Turku, Finland, announced it will publish its unaudited half-year financial results for the period ending 30 June 2026 on We…
Covered by 1 outlet
All coverage · 1 article